|
|
Time course of activity signs at High Resolution OCT during OCT-guided high frequency intravitreal ranibizumab treatment in choroidal neovascularization due to age related macular degeneration
| Third-party funded project |
| Project title |
Time course of activity signs at High Resolution OCT during
OCT-guided high frequency intravitreal ranibizumab treatment in choroidal neovascularization due to age related macular degeneration |
| Principal Investigator(s) |
Prünte, Christian
|
| Organisation / Research unit |
Bereich Spezialfächer (Klinik) / Ophthalmologie USB |
| Project start |
01.10.2011 |
| Probable end |
30.09.2013 |
| Status |
Completed |
| Abstract |
hausinterne Studie, teilfinanziert über Novartis Pharma Schweiz AG, Monbijoustrasse 118, 3001 Bern, (Time course of activity signs at High Resolution OCT during OCT-guided high frequency intravitreal ranibizumab treatment in choroidal neovascularization due to age related macular degeneration).
Keine Fördergelder von Basel! |
| Financed by |
Private Sector / Industry
|
| |
|
|
MCSS v5.8 PRO. 0.475 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
05/05/2024
Research Database / FORSCHUNGSDATENBANK
|
